Sinew Pharma Inc. (TPEX: 6634)
Health Care · Pharmaceuticals · TW
NT$60.90
+5.55% today · +26.9% 1Y
Sinew Pharma Inc. (TPEX: 6634) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $136.34M and employs 57 people.
Over the last twelve months the share price has gained 26.9%, trading between 29.05 and 85.00.
Tweenvest scores Sinew Pharma Inc. across four factors: quality 33/100. Its strongest factor is quality.
6634 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $136.34M
- Revenue (TTM)
- $1.48K
- P/E
- —
- EPS
- -1.66
- Dividend yield
- —
- Beta (5Y)
- 0.58
- 52-week high
- NT$85.00
- 52-week low
- NT$29.05
- Avg volume (3M)
- —
- Shares outstanding
- 71.29M
- Employees
- 57
- Next earnings
- —
About Sinew Pharma Inc.
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
- ISIN
- TW0006634009
- Founded
- 2014
- Listed since
- Jun 30, 2017
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,239.69 | -1.25% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.54 | +0.48% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $149.86 | -1.76% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.88 | -0.68% |
Figures last refreshed Aug 18, 2026.